Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > Cancer community fights back against Covid-19 related delays
  • News

Cancer community fights back against Covid-19 related delays

  • 30 July 2021
  • Janet Fricker
Cancer community fights back against Covid-19 related delays
Total
0
Shares
0
0
0
0
0

The European Cancer Organisation is making materials available to download in 30 different languages to help advocates across Europe lobby national governments to tackle the Covid-19 threat to cancer services in their own countries.

The European Time to Act campaign, first launched in April 2021, believes that one million cancer patients across Europe are currently undiagnosed as a result of the Covid-19 pandemic. The first tranche of national campaigns took place in Poland on 22nd May, followed by Italy on 17th June, and Spain on 25th June. Discussions are now underway for initiatives in Romania, France, Cyprus, Portugal, Croatia, Ireland, UK, Slovakia, Czechia, and Slovenia.

“We are looking to urge the public, cancer patients, policy makers and cancer professionals to rally to ensure that Covid-19 doesn’t continue to undermine our fight against cancer. The scale of the problem is frightening,” says Mark Lawler, a Board member of the European Cancer Organisation, from Queen’s University, Belfast.

As part of the Time to Act campaign, the European Cancer Organisation commissioned data intelligence from the IQVIA Institute for Human Data Science to build a pan-European evidence base of the impact that Covid-19 has had on cancer patients, cancer professionals and cancer services. The research, which was published in the report ‘Cancer Won’t Wait’ (March 2021), revealed:

  • Clinicians across Europe saw 1.5 million fewer cancer patients in the first year of the pandemic.
  • An estimated 100 million cancer screening tests were not performed in Europe as a result of the pandemic.
  • One million cancer patients could be undiagnosed.
  • Treatment delays due to Covid-19 in 2020 affected one in two cancer patients in Europe, and continue to affect one in five.
  • The pandemic has taken its toll on healthcare workers, with four in 10 feeling burnout and three in 10 reportedly showing signs of clinical depression.
  • Due to fears of contracting Covid-19, patients are less likely to attend follow-up visits for early-stage cancer treatment.

The campaign consists of key messages to different groups, with messages for:

  1. Cancer patients and citizens: “Don’t delay.” The campaign urges patients to (i) see their doctor if they have warning signs of cancer ‒ bleeding when you go to the toilet, a lump in your breast, difficulty swallowing, unexpected weight loss or other cancer warning signs; (ii) keep screening and treatment appointments; and (iii) be reassured that cancer services are safe.
  2. For healthcare professionals: “You are not alone.” Healthcare professionals are encouraged to share experiences, information and examples of what has worked and what has not during the Covid-19 pandemic, for the benefit of patients and the cancer community.
  3. For policy makers and health system leaders: “Cancer must be at the top of the agenda.” This means that they must act now to address the cancer backlog, keep cancer services going and ensure they are free of Covid-19, all coordinated to help save lives.

Looking to the future, the Time to Act campaign believes Covid-19 offers the opportunity to ‘reimagine cancer services’, to build back better and smarter.

How you can help!

Elected officials who would like to add their voice to the ‘Time To Act’ calls can do so by contacting Paul Gasc, Special Projects Lead.

Health professionals, patients and members of the public are also encouraged to contact their MEPs to let them know about the Time to Act campaign and ask for their support.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • backlog
  • build back better
  • covid-19
  • European Cancer Organisation
  • Time to Act campaign
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • Articles

How race to track mystery gene with links to three cancers saved millions

  • 23 July 2021
  • Robin McKie
View Post
Next Article
  • Articles
  • Policy

Preventing alcohol-related cancers in Europe: lessons from three countries

  • 30 July 2021
  • Esperanza Escribano
View Post
You May Also Like
View Post
  • News

Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study

  • Yeva Margaryan
  • 8 May 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in April: Oncology’s Top Moments

  • Yeva Margaryan
  • 7 May 2025
View Post
  • News

CancerWorld #102 (April 2025)

  • Yeva Margaryan
  • 22 April 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in March: Oncology’s Top Moments

  • Yeva Margaryan
  • 8 April 2025
View Post
  • News

Ovarian cancer: mechanism conferring resistance to immunotherapy revealed

  • Janet Fricker
  • 21 March 2025
View Post
  • News

Muscular strength and cardiorespiratory fitness improve survival in cancer patients

  • Janet Fricker
  • 20 March 2025
View Post
  • News

CancerWorld #101 (February 2025): The Must-Read Oncology Issue Returns to Print with Exclusive Interviews and Breakthroughs

  • Yeva Margaryan
  • 18 March 2025
View Post
  • News

Low-dose aspirin reduces colorectal cancer recurrence in patients with PI3K alterations

  • Janet Fricker
  • 6 March 2025
search
CancerWorld #101 Download CancerWorld #101 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study
    • 8 May 2025
  • What Caught Our Eye in April: Oncology’s Top Moments
    • 7 May 2025
  • CancerWorld #102 (April 2025)
    • 22 April 2025
  • What Caught Our Eye in March: Oncology’s Top Moments
    • 8 April 2025
  • Ovarian cancer: mechanism conferring resistance to immunotherapy revealed
    • 21 March 2025
Article
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • Istanbul, Ankara take action on HPV vaccination, as government delays promised national programme
    • 1 April 2025
  • Could this dual approach be the frontier that finally gets immunotherapy to work for MSS colorectal cancer?
    • 31 March 2025
Social

Would you follow us ?

Contents
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • “I really care about people.” – Philip Kantoff, A Life in Science and Medicine
    • 5 May 2025
  • What If the World’s Leading Prostate Cancer Epidemiologist Opened a Restaurant? A Conversation with Lorelei Mucci- A Harvard Scientist, A Mother, A Leader
    • 23 April 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.